Laminin C1 expression by uterine carcinoma cells is associated with tumor progression

Laminin C1 expression by uterine carcinoma cells is associated with tumor progression

Na minha lista:

Detalhes bibliográficos
Principais autores:	Hiroyasu Kashima, Ren‐Chin Wu, Yihong Wang, A.K. Sinno, Tsutomu Miyamoto, Tanri Shiozawa, Tian‐Li Wang, Amanda N. Fader, Ie‐Ming Shih
Formato:	Artigo
Idioma:	Inglês
Publicado em:	2015
Acesso em linha:	https://doi.org/10.1016/j.ygyno.2015.08.025 https://www.sciencedirect.com/science/article/am/pii/S0090825815301165
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

Laminin C1 expression by uterine carcinoma cells is associated with tumor progression
por: Kashima, Hiroyasu, et al.
Publicado em: (2015)

Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells
por: Y. Mitsuhashi, et al.
Publicado em: (2012)

A case of pure-type ovarian squamous cell carcinoma producing granulocyte-colony stimulating factor
por: Kobara, Hisanori, et al.
Publicado em: (2017)

<i>BRAF</i> Mutation in Endometrial Carcinoma and Hyperplasia: Correlation with <i>KRAS</i> and <i>p53</i> Mutations and Mismatch Repair Protein Expression
por: Yuzhen Feng, et al.
Publicado em: (2005)

Usefulness of a management protocol for patients with cervical multicystic lesions: A retrospective analysis of 94 cases and the significance of GNAS mutation
por: Ando, Hirofumi, et al.
Publicado em: (2016)

Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
por: Suzuki, Akihisa, et al.
Publicado em: (2010)

Overexpression of Hedgehog Signaling Molecules and Its Involvement in the Proliferation of Endometrial Carcinoma Cells
por: Yuzhen Feng, et al.
Publicado em: (2007)

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells()
por: Mvunta, David Hamisi, et al.
Publicado em: (2017)

SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells
por: David Hamisi Mvunta, et al.
Publicado em: (2017)

Uterine serous carcinoma: key advances and novel treatment approaches
por: J. Stuart Ferriss, et al.
Publicado em: (2021)

Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
por: Miyamoto, Tsutomu, et al.
Publicado em: (2016)

αGlcNAc and its catalyst α4GnT are diagnostic and prognostic markers in uterine cervical tumor, gastric type
por: Ida, Koichi, et al.
Publicado em: (2019)

Robotic-assisted surgery in gynecologic oncology
por: A.K. Sinno, et al.
Publicado em: (2014)

Worsening cytology and lesion enlargement are useful indicators for malignant transformation of lobular endocervical glandular hyperplasia during follow-up: A case report
por: Kobara, Hisanori, et al.
Publicado em: (2020)

Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado em: (2011)

The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma
por: Kuhn, Elisabetta, et al.
Publicado em: (2012)

The Diagnostic and Biological Implications of Laminin Expression in Serous Tubal Intraepithelial Carcinoma
por: Elisabetta Kuhn, et al.
Publicado em: (2012)

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target
por: Ryoichi Asaka, et al.
Publicado em: (2015)

Loss of ARID1A Expression Correlates with Stages of Tumor Progression in Uterine Endometrioid Carcinoma
por: Mao, Tsui-Lien, et al.
Publicado em: (2013)

Loss of ARID1A Expression Correlates With Stages of Tumor Progression in Uterine Endometrioid Carcinoma
por: Tsui-Lien Mao, et al.
Publicado em: (2013)

Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado em: (2021)

Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado em: (2014)

Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer
por: Yen, Ting-Tai, et al.
Publicado em: (2020)

Molecular Classification and Emerging Targeted Therapy in Endometrial Cancer
por: Ting‐Tai Yen, et al.
Publicado em: (2019)

Mice-lacking LMP2, immuno-proteasome subunit, as an animal model of spontaneous uterine leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado em: (2010)

Limited frequency of malignant change in lobular endocervical glandular hyperplasia
por: Kobara, Hisanori, et al.
Publicado em: (2020)

Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models
por: Yusuke Kobayashi, et al.
Publicado em: (2015)

Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma
por: Chui, M. Herman, et al.
Publicado em: (2014)

Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma
por: Elisabetta Kuhn, et al.
Publicado em: (2013)

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis
por: Guan, Bin, et al.
Publicado em: (2014)

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis
por: Bin Guan, et al.
Publicado em: (2014)

Analysis of gastric-type mucinous carcinoma of the uterine cervix — An aggressive tumor with a poor prognosis: A multi-institutional study
por: Shin Nishio, et al.
Publicado em: (2019)

Sawtooth fetal heart rate pattern associated with a favorable neurological outcome in an infant: a case report
por: Ohira, Satoshi, et al.
Publicado em: (2019)

The emerging roles of ARID1A in tumor suppression
por: Wu, Ren-Chin, et al.
Publicado em: (2014)

The emerging roles of ARID1A in tumor suppression
por: Ren‐Chin Wu, et al.
Publicado em: (2014)

Whole-exome sequencing of lobular endocervical glandular hyperplasia
por: Ida, Koichi, et al.
Publicado em: (2019)

High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome
por: Cope, Leslie, et al.
Publicado em: (2012)

Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
por: Bin Guan, et al.
Publicado em: (2011)

Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas
por: Motohiko Shimizu, et al.
Publicado em: (1999)

Somatic Mutations of PPP2R1A in Ovarian and Uterine Carcinomas
por: Ie‐Ming Shih, et al.
Publicado em: (2011)